Molecular epidemiology of malaria in Cameroon.: XVI.: Longitudinal surveillance of in vitro pyrimethamine resistance in Plasmodium falciparum

被引:19
作者
Basco, LK [1 ]
机构
[1] Org Coordinat Lutte Contre Endemies & Afrique Cen, Lab Rech Paludisme, Inst Rech Dev, Unite Rech Paludologie Afro Trop, Yaounde, Cameroon
关键词
D O I
10.4269/ajtmh.2003.69.174
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Clinical observations have shown that pyrimethamine resistance develops rapidly in endemic countries where antifolate drugs are used massively for the treatment of Plasmodium falciparum infections. To analyze this phenomenon, the in vitro response of clinical isolates to pyrimethamine and the dihydrofolate reductase (dhfr) gene sequence were analyzed in 2000-2001 and compared with the results obtained since 1994 in Yaounde, Cameroon. Of 139 samples obtained in 2000-2001, 10 (7.2%) isolates were of the wild-type, 116 had pure mutant alleles (2 [1.4%] with a single mutation, 11 [7.9%] with double mutations, and 103 [74.1%] with triple mutations), and 13 (9.4%) had mixed alleles. With the exception of a single isolate with triple mutations (50% inhibitory concentration [IC50] = 84.3 nM), all isolates with pure wild-type dhfr alleles (IC50 < 100 nM) and those with pure mutant dhfr alleles (between 1 and 3 point mutations; IC50 greater than or equal to 100 nM) were clearly distinguished by in vitro drug sensitivity assays. The results of the two methods are highly correlated, and both methodologic approaches indicate an increasing proportion of pyrimethamine-resistant isolates in Yaounde over the past eight years (42-45% in 1994-1995, 63-67% in 1997-1998, and 88-92% in 2000-2001). At present, clinical isolates carrying triple dhfr mutations predominate in Yaounde. This situation calls for a regular surveillance of the efficacy of antifolate drugs by all available means, including clinical evaluation, in vitro drug sensitivity assays, molecular markers, and pharmacologic studies.
引用
收藏
页码:174 / 178
页数:5
相关论文
共 19 条
[1]   Molecular epidemiology of malaria in Yaounde, Cameroon IV. Evolution of pyrimethamine resistance between 1994 and 1998 [J].
Basco, LK ;
Ringwald, P .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (05) :802-806
[2]   Molecular epidemiology of malaria in Cameroon.: XI.: Geographic distribution of Plasmodium falciparum isolates with dihydrofolate reductase gene mutations in southern and central Cameroon [J].
Basco, LK ;
Ndounga, M ;
Tejiokem, M ;
Ngane, VF ;
Youmba, JC ;
Ringwald, P ;
Soula, G .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 67 (04) :378-382
[3]   Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadosine-pyrimethamine in patients with acute uncomplicated falciparum malaria [J].
Basco, LK ;
Tahar, R ;
Keundjian, A ;
Ringwald, P .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (02) :624-628
[4]   In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment [J].
Curtis, J ;
Duraisingh, MT ;
Warhurst, DC .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1429-1433
[5]   Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali [J].
Diourté, Y ;
Djimdé, A ;
Doumbo, OK ;
Sagara, I ;
Coulibaly, Y ;
Dicko, A ;
Diallo, M ;
Diakité, M ;
Cortese, JF ;
Plowe, CV .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 60 (03) :475-478
[6]  
FIDOCK DA, 1999, MALARIA MOL CLIN ASP, P217
[7]   AMINO-ACIDS IN THE DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE GENE OF PLASMODIUM-FALCIPARUM INVOLVED IN CYCLOGUANIL RESISTANCE DIFFER FROM THOSE INVOLVED IN PYRIMETHAMINE RESISTANCE [J].
FOOTE, SJ ;
GALATIS, D ;
COWMAN, AF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3014-3017
[8]   The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector [J].
Hogh, B ;
Gamage-Mendis, A ;
Butcher, GA ;
Thompson, R ;
Begtrup, K ;
Mendis, C ;
Enosse, SM ;
Dgedge, M ;
Barreto, J ;
Eling, W ;
Sinden, RE .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (02) :176-182
[9]  
MABERTI S, 1960, Arch Venez Med Trop Parasitol Med, V3, P239
[10]   Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum:: Genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites [J].
Nzila, AM ;
Mberu, EK ;
Sulo, J ;
Dayo, H ;
Winstanley, PA ;
Sibley, CH ;
Watkins, WM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :991-996